BIOCRYST PHARMACEUTICALS INC - COM - Put Institutional Ownership

CUSIP: 09058V953

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / COM
Price per share
$7.80
All holders as of 31 Dec 2025
Q4 2025
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 09058V953?
CUSIP 09058V953 identifies 09058V953 - BIOCRYST PHARMACEUTICALS INC - COM - Put in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 0 institutional investors reported holding shares of BIOCRYST PHARMACEUTICALS INC - COM - Put.

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - COM - Put across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 $7.80 0
2025 Q3 $7.59 0
2025 Q2 $8.96 0
2025 Q1 $7.50 0
2024 Q4 $7.52 0
2024 Q3 $7.60 0
2024 Q2 $6.18 0
2024 Q1 $5.07 0
2023 Q4 $5.99 0
2023 Q3 $7.08 0
2023 Q2 $7.04 0
2023 Q1 $8.34 0
2022 Q4 $11.48 0
2022 Q3 $12.60 0
2022 Q2 $10.58 0
2022 Q1 $16.25 0
2021 Q4 $13.85 0
2021 Q3 $15.32 0
2021 Q2 $15.81 0
2021 Q1 $10.17 0
2020 Q4 $376.18 0
2020 Q3 $172.80 0
2020 Q2 $240.48 0
2020 Q1 $101.00 0
2019 Q4 $168.41 0
2019 Q3 $144.29 0
2019 Q2 $190.92 0
2019 Q1 $8.00 0
2018 Q4 $8.07 0
2018 Q3 $7.61 0
2018 Q2 $5.76 0
2018 Q1 $58.97 0
2017 Q4 $4.91 0
2017 Q3 $17.44 0
2017 Q2 $70.68 0
2017 Q1 $23.94 0
2016 Q4 $117.67 0
2016 Q3 $21.07 0
2016 Q2 $500.00 0
2016 Q1 $500.00 0
2015 Q4 $27.90 0
2015 Q3 $60.05 0
2015 Q2 $15.00 0
2015 Q1 $60.11 0
2014 Q4 $12.19 0
2014 Q3 $9.78 0
2014 Q2 $12.75 0
2014 Q1 $10.57 0